Baseline cognitive functions among elderly patients with localised breast cancer

European Journal of Cancer

Volumn 50, Issue 13, 2014, Pages 2181-2189

  Lange, Marie ^a,b,c,d,e   Giffard, Bénédicte ^a,b,c,d,i   Noal, Sabine ^b   Rigal, Olivier ^f   Kurtz, Jean Emmanuel ^g,j   Heutte, Natacha ^b,e,h   Lévy, Christelle ^b   Allouache, Djelila ^b   Rieux, Chantal ^b   Fel, Johan Le ^b,f   Daireaux, Aurélie ^b   Clarisse, Bénédicte ^b   Veyret, Corinne ^f   Barthélémy, Philippe ^g,j   Longato, Nadine ^g,j   Eustache, Francis ^a,b,c,d   Joly, Florence ^b,d,e  

^a Centre Cyceron   (France)

^b CENTRE FRANÇOIS BACLESSE   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

^e Axe 2: 'Biology and Innovative Therapeutics for Locally Aggressive Cancers'   (France)

^f CENTRE HENRI BECQUEREL   (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h UNIVERSITÉ DE CAEN   (France)

ⁱ CHU CÔTE DE NACRE   (France)

^j HÔPITAL DE HAUTEPIERRE   (France)

more..

Author keywords

Ageing; Breast neoplasms; Cognition disorders; Neuropsychology; Quality of life

Indexed keywords

AGE; AGED; BREAST NEOPLASMS; COGNITION; COGNITION DISORDERS; FEMALE; HUMAN; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE;

AGE FACTORS; AGED; BREAST NEOPLASMS; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84905121052     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.05.026     Document Type: Article

References (34)

1. F. Joly, O. Rigal, S. Noal, and B. Giffard Cognitive dysfunction and cancer: which consequences in terms of disease management? Psychooncology 20 2011 1251 1258
2. T.A. Ahles Brain vulnerability to chemotherapy toxicities Psychooncology 21 2012 1141 1148
3. C.S. Scherling, and A. Smith Opening up the window into "Chemobrain": a neuroimaging review Sensors (Basel) 13 2013 3169 3203
4. T.A. Ahles, and A.J. Saykin Candidate mechanisms for chemotherapy-induced cognitive changes Nat Rev Cancer 7 2007 192 201
5. A. Hurria, C. Rosen, and C. Hudis et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study J Am Geriatr Soc 54 2006 925 931
6. R.M. Crum, J.C. Anthony, S.S. Bassett, and M.F. Folstein Population-based norms for the mini-mental state examination by age and educational level JAMA 269 1993 2386 2391
7. M. Kalafat, L. Hugonot-Diener, and J. Poitrenaudl French standardization of the "Mini Mental State" (MMS) Greco version Revue de Neuropsychologie 13 2 2003 209 236
8. M.F. Folstein, S.E. Folstein, and P.R. Mchugh "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
9. D. Cardebat, B. Doyon, and M. Puel et al. Formal and semantic lexical evocation in normal subjects. performance and dynamics of production as a function of sex, age and educational level Acta Neurol Belg 90 1990 207 217
10. A. Rey Manual of copy and memory reproduction test of complex geometric figures 1959 Éditions Centre De Psychologie Appliquée Paris
11. R. Reitan Validity of trail making tests as an indicator of organic brain damage Percept Motor Skills 8 1958 271 276
12. M. Van Der Linden, S. Adam, A. Agniel, C. Antérion-Thomas, C. Baisset-Mouly, and F. Coyette et al. Assessment of memory impairment 2004 Solal Marseille
13. D. Wechsler Wechsler adult intelligence scale-III 1997 The Psychological Corporation San Antonio
14. F. Joly, M. Lange, and O. Rigal et al. French version of the functional assessment of cancer therapy-cognitive function (FACT-Cog) version 3 Supp Care Cancer 20 2012 3297 3305
15. L.I. Wagner, J. Sweet, and Z. Butt et al. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument J Support Oncol 7 2009 W32 W39
16. A.T. Beck, and A. Beamesderfer Assessment of depression: the depression inventory Mod Probl Pharmacopsychiatry 7 1974 151 169
17. S.D. Spielberger Manual for the state-trait anxiety inventory (STAI) 1983 Consulting Psychologists Press Palo Alto, CA
18. S.B. Yellen, D.F. Cella, and K. Webster et al. Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system J Pain Symptom Manage 13 1997 63 74
19. M.J. Brady, D.F. Cella, and F. Mo et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument J Clin Oncol 15 1997 974 986
20. D.F. Cella, D.S. Tulsky, and G. Gray et al. The functional assessment of cancer therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579
21. J.P. Clement, R.F. Nassif, J.M. Leger, and F. Marchan Development and contribution to the validation of a brief French version of the Yesavage geriatric depression scale Encephale 23 1997 91 99
22. M.P. Lawton, and E.M. Brody Assessment of older people: self-maintaining and instrumental activities of daily living Gerontologist 9 1969 179 186
23. S. Katz, T.D. Downs, H.R. Cash, and R.C. Grotz Progress in development of the index of ADL Gerontologist 10 1970 20 30
24. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. Mackenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
25. J.S. Wefel, J. Vardy, T. Ahles, and S.B. Schagen International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer Lancet Oncol 12 2011 703 708
26. J.S. Wefel, D.J. Vidrine, and T.L. Veramonti et al. Cognitive impairment in men with testicular cancer prior to adjuvant therapy Cancer 117 2011 190 196
27. L.G. Ingraham, and C.B. Aiken An empirical approach to determining criteria for abnormality in test batteries with multiple measures Neuropsychology 10 1996 120 124
28. C. Wratten, J. Kilmurray, and S. Nash et al. Fatigue during breast radiotherapy and its relationship to biological factors Int J Radiat Oncol Biol Phys 59 2004 160 167
29. P.S. Brucker, K. Yost, and J. Cashy et al. General population and cancer patient norms for the functional assessment of cancer therapy-general (Fact-G) Eval Health Prof 28 2005 192 211
30. K. Hede Chemobrain is real but may need new name J Natl Cancer Inst 100 2008 pp. 162-163, 169
31. A. Hurria, G. Somlo, and T. Ahles Renaming "Chemobrain" Cancer Invest 25 2007 373 377
32. T.A. Ahles, J.C. Root, and E.L. Ryan Cancer- and cancer treatment-associated cognitive change: an update on the state of the science J Clin Oncol 30 2012 3675 3686
33. M.J. Pullens, J. De Vries, and J.A. Roukema Subjective cognitive dysfunction in breast cancer patients: a systematic review Psychooncology 19 2010 1127 1138
34. P.A. Ganz, L. Kwan, and S.A. Castellon et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance J Natl Cancer Inst 105 2013 791 801